0 false false false false false false false false false false true false false false false false false No description of principal activity 2025-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15542273 2025-04-01 2026-03-31 15542273 2026-03-31 15542273 2025-03-31 15542273 2024-03-05 2025-03-31 15542273 2025-03-31 15542273 2024-03-04 15542273 bus:Director1 2025-04-01 2026-03-31 15542273 core:WithinOneYear 2026-03-31 15542273 core:WithinOneYear 2025-03-31 15542273 bus:Micro-entities 2025-04-01 2026-03-31 15542273 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 15542273 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 15542273 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15542273 bus:FullAccounts 2025-04-01 2026-03-31
COMPANY REGISTRATION NUMBER: 15542273
Parissis Medical Ltd
Filleted Unaudited Financial Statements
31 March 2026
Parissis Medical Ltd
Statement of Financial Position
31 March 2026
Period from
Year to
5 Mar 24 to
31 Mar 26
31 Mar 25
£
£
Fixed assets
9,694
12,207
-------
--------
Current assets
74,744
7,402
Creditors: amounts falling due within one year
74,008
56,145
--------
--------
Net current assets/(liabilities)
736
( 48,743)
--------
--------
Total assets less current liabilities
10,430
( 36,536)
--------
--------
Capital and reserves
10,430
( 36,536)
--------
--------
Notes to the financial statements
1. Director's advances, credits and guarantees
There are no transactions with directors requiring further disclosure.
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 2 June 2026 , and are signed on behalf of the board by:
Mr Mondrian Parissis
Director
Company registration number: 15542273
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 17-19 Sheen Road, Richmond, Lodnon, TW9 1AD.